Search Results - "Slack, Daniel J."

Further data against the use of cyproterone acetate in gender affirming hormone therapy regimens by Slack, Daniel J, Safer, Joshua D

Get full text

Erythrocytosis Is Rare With Exogenous Testosterone in Gender-Affirming Hormone Therapy by Krishnamurthy, Nithya, Slack, Daniel J, Kyweluk, Moira, Cullen, Olivia, Kirkley, Jerrica, Safer, Joshua D

“…Studies have found a variable incidence of erythrocytosis among people using testosterone as part of gender-affirming hormone therapy (GAHT). To examine the…”
Get full text

CARDIOVASCULAR HEALTH MAINTENANCE IN AGING INDIVIDUALS: THE IMPLICATIONS FOR TRANSGENDER MEN AND WOMEN ON HORMONE THERAPY by Slack, Daniel J, Safer, Joshua D

“…To review screening guidelines for cardiometabolic disease in aging patients and review literature describing the effect of hormone therapy (HT) on several key…”
Get more information

Characteristics of rare disease marketing applications associated with FDA product approvals 2006–2010 by Pariser, Anne R., Slack, Daniel J., Bauer, Larry J., Warner, Catherine A., Tracy, LaRee A.

“…► We analyze rare disease marketing applications submitted to FDA from 2006 to 2010. ► We examine characteristics associated with rare disease drug approvals…”
Get full text

Participants With Schizophrenia Retain the Information Necessary for Informed Consent During Clinical Trials by FISCHER, Bernard A, McMAHON, Robert P, MEYER, Walter A, SLACK, Daniel J, APPELBAUM, Paul S, CARPENTER, William T

“…Cognitive impairment is a characteristic of schizophrenia. This impairment may affect the retention of information required for ongoing knowledgeable…”
Get full text

5158 Estrogen for Feminizing Gender Affirming Hormone Therapy: Understanding the Influence of Route of Administration and Dose on Serum Estradiol and Testosterone Levels by Slack, Daniel J, Via Ioschpe, Anais Di, Saturno, Michael, Kihuwa-Mani, Sky, Amakiri, Uchechukwu, Karim, Subha, Guerra, Dan, Safer, Joshua David

“…Abstract Disclosure: D.J. Slack: None. A. Di Via Ioschpe: None. M. Saturno: None. S. Kihuwa-Mani: None. U. Amakiri: None. S. Karim: None. D. Guerra: None. J.D…”
Get full text

5158 Estrogen for Feminizing Gender Affirming Hormone Therapy: Understanding the Influence of Route of Administration and Dose on Serum Estradiol and Testosterone Levels by Slack, Daniel J, Di Via Ioschpe, Anais, Saturno, Michael, Kihuwa-Mani, Sky, Amakiri, Uchechukwu, Karim, Subha, Guerra, Dan, Safer, Joshua David

“…Abstract Disclosure: D.J. Slack: None. A. Di Via Ioschpe: None. M. Saturno: None. S. Kihuwa-Mani: None. U. Amakiri: None. S. Karim: None. D. Guerra: None. J.D…”
Get full text

A COMPARISON OF FREQUENCY, INTERVAL, AND TIME-SAMPLING METHODS OF DATA COLLECTION by Repp, Alan C., Roberts, David M., Slack, Daniel J., Repp, Christina F., Berkler, Margo S.

“…Data representing high, medium, and low response rates in constant and nonconstant patterns were generated by electromechanical equipment to determine whether…”
Get full text

Reducing Responding of Retarded Persons by Dro Schedules Following a History of Low-Rate Responding: A Comparison of Ascending Interval Sizes by Repp, Alan C., Slack, Daniel J.

Get full text